Ventas, Inc.

NYSE:VTR

REIT - Healthcare Facilities

Real Estate
$88.20 -0.34%

-$0.28 today

Market cap
$46.64B
Beta
0.73
P/E (TTM)
149.7
EPS (TTM)
$0.55
Dividend yield
2.39%
52W Low $61.76High $91.06

Volume 3.72M

Average 4.09M

VTR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Ventas, Inc.NYSE: VTR

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $1.04B rose 25.9% year over year, behind the +115.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at +39.4% a year.

Context

  • Cost of revenue amounted to 105.9% of revenue in FY2025, up 48.5 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +25.9% toward the trailing-twelve-month pace of +115.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.04B+3.9% QoQ
Last fiscal yearDec 2025
$6.18B+118.5% YoY
LTMJun 2026
$6.61B+115.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+25.9%——
1 year+118.5%——
3-year CAGR+39.4%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
6.18B USD
Year-over-year change
+118.5%
4-year CAGR
+31.1%

Cost of Revenue vs competitors

How VTR compares with its peers on the latest reported figures

  • VTR's LTM Jun 2026 cost of revenue of $6.61B is the highest of the 11 companies compared; the peer median is $276.99M.
  • Its year-over-year change of +115.3% is the 6th highest of 10, against a peer median of +131.0%.
  • Cost of revenue amounts to 102.6% of revenue for VTR, versus a peer median of 41.5%.
VTR Competitors Peer median
Cost of Revenue for VTR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VTRVentas, Inc.LTM Jun 2026$6.61B +115.3%+39.4%102.6%
WELLWelltower Inc.LTM Sep 2026$6.14B +3.0%+22.2%44.8%
DOCHealthpeak Properties, Inc.LTM Sep 2026$2.58B +131.0%+36.4%115.1%
AHRAmerican Healthcare REIT, Inc.LTM Sep 2026$2.25B +29.1%+11.9%84.3%
OHIOmega Healthcare Investors, Inc.LTM Jun 2026$362.27M +2568.6%+250.1%28.0%
SBRASabra Health Care REIT, Inc.LTM Jun 2026$327.99M +37.0%+18.6%38.2%
NHINational Health Investors, Inc.LTM Sep 2026$225.99M +1907.9%+190.4%49.4%
NHPNational Healthcare Properties, Inc. (NHP)LTM Dec 2025$218.25M —+0.8%63.8%
LTCLTC Properties, Inc.LTM Sep 2026$139.08M +262.4%+61.6%35.3%
CTRECareTrust REIT, Inc.LTM Sep 2026$136.24M +1127.6%+174.9%22.1%
MPTMedical Properties Trust, Inc.LTM Jun 2026$28.46M -12.9%-7.3%2.8%
Peer median (excluding VTR) $276.99M+131.0%+29.3%41.5%

Competitors are the stored peer set for VTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.83B4.13B4.5B4.92B5.83B
Cost of Revenue2.09B2.28B2.56B2.83B6.18B
Gross Profit1.74B1.85B1.94B2.1B(344.22M)
Gross Margin45.4%44.7%43.1%42.6%-5.9%
Research & Development00000
Selling, General & Admin129.76M144.87M148.88M162.99M177.4M
Operating Expenses1.32B1.36B1.52B1.42B(1.17B)
Depreciation & Amortization978M1.09B1.17B1.17B1.38B
EBITDA1.48B1.5B1.7B1.82B2.24B
EBITDA Margin38.6%36.3%37.8%37.0%38.4%
Operating Income421.43M483.85M415.51M681.23M826.81M
Operating Margin11.0%11.7%9.2%13.8%14.2%
Interest Income000022.59M
Interest Expense440.09M467.56M574.11M602.84M612.25M
Other Income / Expenses(360.05M)(541.7M)(455.35M)(630.65M)(579.44M)
Income Before Tax61.39M(57.86M)(39.84M)50.58M247.37M
Pre-Tax Margin1.6%-1.4%-0.9%1.0%4.2%
Income Tax Expense4.83M(16.93M)(9.54M)(37.78M)(14.15M)
Net Income49.01M(47.45M)(40.97M)81.15M251.38M
Net Margin1.3%-1.1%-0.9%1.6%4.3%
EPS (Basic)0.13(0.13)(0.10)0.200.55
EPS (Diluted)0.13(0.13)(0.10)0.190.54
Weighted Avg Shares382.79M373.37M401.81M411.77M455.08M
Weighted Avg Shares (Diluted)386.3M373.37M405.67M416.37M462.62M

Ventas, Inc.

NYSE:VTR

Intrinsic Alpha fair value

Locked

Current Price

$88.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.